O'Shaughnessy Asset Management, LLC Biomarin Pharmaceutical Inc Transaction History

O'Shaughnessy Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$85.07 - $94.48 $249,084 - $276,637	2,928 New	2,928 $259,000
Q3 2021 Nov 10, 2021	SELL	$74.77 - $85.47 $448 - $512	-6 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$72.61 - $90.2 $871 - $1,082	-12 Reduced 66.67%	6 $1,000
Q3 2020 Nov 12, 2020	SELL	$71.87 - $131.03 $2,731 - $4,979	-38 Reduced 67.86%	18 $1,000
Q2 2020 Aug 13, 2020	BUY	$79.55 - $124.22 $3,261 - $5,093	41 Added 273.33%	56 $7,000
Q4 2019 Feb 12, 2020	BUY	$64.27 - $86.37 $964 - $1,295	15 New	15 $1,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.